Chronic PPI exposure tied to hyperparathyroidism in elderly

Chronic PPI exposure tied to hyperparathyroidism in elderly
Chronic proton pump inhibitor exposure is associated with mild hyperparathyroidism in elderly adults, according to a study published in the October issue of the Journal of the American Geriatrics Society.

(HealthDay)—Chronic proton pump inhibitor (PPI) exposure is associated with mild hyperparathyroidism in elderly adults, according to a study published in the October issue of the Journal of the American Geriatrics Society.

Andrew M. Hinson, M.D., from the University of Arkansas for Medical Sciences in Little Rock, and colleagues examined the effect of PPIs with and without concurrent bisphosphonates (BPs) on (PTH), vitamin D, and calcium in a retrospective chart review of individuals aged 60 years and older. Data were included for 80 individuals meeting inclusion criteria.

The researchers found that, compared with no PPI exposure, chronic PPI exposure correlated with significantly higher PTH (65.5 versus 30.3 pg/mL; P < 0.001) and lower calcium (9.1 versus 9.4 mg/dL; P = 0.02). Compared with BP therapy alone, chronic PPI exposure with concurrent BP therapy was associated with significantly higher PTH (65.2 versus 43.4 pg/mL; P = 0.05) and lower (9.2 versus 9.6 mg/dL; P = 0.04).

"Based on the present study, chronic PPI exposure in elderly adults is associated with mild hyperparathyroidism regardless of concurrent oral BP administration," the authors write.


Explore further

Electronic alert cuts proportion of IV proton pump inhibitors

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2015 HealthDay. All rights reserved.

Citation: Chronic PPI exposure tied to hyperparathyroidism in elderly (2015, November 3) retrieved 14 May 2021 from https://medicalxpress.com/news/2015-11-chronic-ppi-exposure-tied-hyperparathyroidism.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments